Metagenomi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MGX and other ETFs, options, and stocks.About MGX
Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform.
MGX Key Statistics
Stock Snapshot
The current Metagenomi Therapeutics(MGX) stock price is $1.26, with a market capitalization of 47.62M. The stock trades at a price-to-earnings (P/E) ratio of -0.55.
On 2026-07-05, Metagenomi Therapeutics(MGX) stock moved within a range of $1.18 to $1.27. With shares now at $1.26, the stock is trading +7.2% above its intraday low and -0.8% below the session's peak.
Trading volume for Metagenomi Therapeutics(MGX) stock has reached 355.82K, versus its average volume of 159.4K.
The stock's 52-week range extends from a low of $1.13 to a high of $3.95.
The stock's 52-week range extends from a low of $1.13 to a high of $3.95.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.